Nonalcoholic fatty liver disease affects a substantial proportion of the general population worldwide. This high prevalence of nonalcoholic fatty liver disease has important consequences in the donor selection process for liver transplantation, and in the posttransplant period given the high recurre
Fatty Liver and Liver Transplantation
β Scribed by Koehler, Edith; Watt, Kymberly; Charlton, Michael
- Book ID
- 121911313
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 149 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1089-3261
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatic steatosis is a recognized problem in patients after orthotopic liver transplant (OLT). However, de novo development of nonalcoholic fatty liver disease (NAFLD) has not been well described. The aim of this study was to determine the prevalence and predictors of de novo NAFLD after OLT. A retr
Achieving long-term graft survival and mortality is the primary goal of liver transplantation (LT). However, disease recurrence remains a stumbling block, especially among patients with hepatitis C. In such patients, worse outcomes may be associated with comorbidities (i.e., hyperlipidemia, hyperten
Nonalcoholic steatohepatitis (NASH) may account for many cases of cryptogenic cirrhosis. If so, then steatosis might recur after liver transplantation. Two thousand fifty-two patients underwent primary liver transplantation for chronic liver disease between 1986 and 2004. Serial liver biopsy samples